TBIO
Telesis Bio, Inc. Common Stock
TBIO
TBIO
Delisted
TBIO was delisted on the 27th of September, 2024.
24 hedge funds and large institutions have $15.1M invested in Telesis Bio, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 6 increasing their positions, 8 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
80% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 10
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $24K
Holders
24
Holding in Top 10
1
Calls
–
Puts
$24K
Top Buyers
| 1 | +$258K | |
| 2 | +$29K | |
| 3 | +$18.4K | |
| 4 |
Simplex Trading
Chicago,
Illinois
|
+$4.94K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$4.45K |
Top Sellers
| 1 | -$86.8K | |
| 2 | -$85K | |
| 3 | -$76.7K | |
| 4 |
D.E. Shaw & Co
New York
|
-$66K |
| 5 |
E
Ergoteles
New York
|
-$63K |